Gulf Pharmaceutical Industries (Julphar) will hold its Annual General Meeting on April 25, 2026, to approve the financial statements for the year ended December 31, 2025.
The Board of Directors has recommended that no dividends be distributed to shareholders for the 2025 financial year.
Nominations for nine seats on the Board of Directors are open from March 31, 2026, until April 9, 2026.
The meeting agenda includes the election of Board members and the ratification of the appointments of Taghreed Al Shunnar and Vinod Nagappan Nagappan.